Twist Bioscience Corporation (TWST) Total liabilities 2018–2025
Twist Bioscience Corporation (TWST) total liabilities at each fiscal year-end, per SEC filings.
$168.9MFY2025 · since FY2018: $26.7M → $168.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $168.9M | +19.3% |
| FY2024 | $141.6M | -7.4% |
| FY2023 | $153.0M | -11.1% |
| FY2022 | $172.0M | +41.8% |
| FY2021 | $121.3M | +93.7% |
| FY2020 | $62.6M | +79.4% |
| FY2019 | $34.9M | +30.6% |
| FY2018 | $26.7M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More TWST financial trends
TWST RevenueTWST Net incomeTWST Net marginTWST Gross profitTWST Gross marginTWST Operating incomeTWST Operating marginTWST Operating cash flowTWST Free cash flowTWST Capital expendituresTWST Return on equityTWST Stock buybacksTWST Dividends paidTWST Total assetsTWST Shareholders’ equityTWST overview →